It addresses topics such as talking with
average risk patients about BRCA1 / BRCA2 testing and when to order a multi-gene panel for breast cancer risk.
Not exact matches
The
average death rate following the procedure, adjusted to take account of varying
patient risk levels, was 4.03 percent, Carroll said.
Results suggest that while isotretinoin was associated with a change in the
average value of some laboratory tests (white blood cell count and hepatic and lipid panels), the
average change across a
patient group did not meet the criteria for high -
risk and the proportion of
patients with laboratory abnormalities was low, the authors report.
However, in the largest study of its kind so far, scientists from the German Cancer Research Center (DKFZ) in Heidelberg have now shown that the
risk of death from heart disease in breast cancer
patients following radiotherapy or chemotherapy is no higher than it is among the
average population.
Rheumatoid arthritis
patients are likelier than the
average person to develop chronic kidney disease, and more severe inflammation in the first year of rheumatoid arthritis, corticosteroid use, high blood pressure and obesity are among the
risk factors, new Mayo Clinic research shows.
The
average 90 - day spending on
patients in the study is almost $ 27,500; for every additional increase in spending of roughly $ 8,500, the researchers found a reduction in mortality
risk of about 2 percentage points.
Currently, pacemaker batteries last seven years on
average, requiring frequent replacements, which may pose
patients to a potential
risk involved in medical procedures.
In the group of
patients with aggressive, or high
risk, prostate cancer, the
average number of days from diagnosis to surgery or radiation treatment was 96 days for Caucasian
patients, and 105 days for African American
patients.
Respondents were also asked to report on whether they generally recommended routine screening mammograms to
average -
risk patients with no family history or prior breast issues in groups aged 40 - 44, 45 - 49 and older than 75 years.
Research led by the University of Birmingham has discovered that
patients who suffer from both Type 2 diabetes and obstructive sleep apnea are at greater
risk of developing a condition that leads to blindness within an
average period of less than four years.
When comparing the two groups, the rate of weight gain was almost double on higher - versus lower - calorie diets, and
patients receiving more calories were hospitalized for an
average of seven fewer days, without an increased
risk of refeeding syndrome.
Calibration is the agreement between the predicted
risk and actual outcomes on
average, and across the spectrum of predicted
risk — from low to high, said Mark E. Cohen, PhD, one of the study's authors and a statistical manager in the ACS Division of Research and Optimal
Patient Care.
The
average age of
patients in the study group was 84.5 years, and many had additional serious health
risks.
We get heavily hyped drugs like Avastin, which shrank tumors without adding significant time to cancer
patients» lives (and increased the incidence of heart failure and blood clots to boot); Avandia, which lowered blood sugar in diabetics but raised the
average risk of heart attack by 43 percent; torcetrapib, which raised both good cholesterol and death rates; and Flurizan, which reduced brain plaque but failed to slow the cognitive ravages of Alzheimer's disease before trials were finally halted in 2008.
Researchers determined the low,
average or high performing hospitals based upon a calculation of the relative
risk that a
patient would experience a major complication.
Analyzing the baseline
risk factors and health conditions of
patients in each grouping, they found the
average age of STEMI
patients decreased from 64 to 60, and the prevalence of obesity increased from 31 to 40 percent between the first five - year span and the last five - year span.
Most Crohn's disease
patients who carried the
risk mutation developed the disease on
average six years earlier than those who did not carry this mutation.
Patients in the study averaged three such shifts, which meant that their risk of dying increased by more than six percent compared with patients with access to fully staffed nursin
Patients in the study
averaged three such shifts, which meant that their
risk of dying increased by more than six percent compared with
patients with access to fully staffed nursin
patients with access to fully staffed nursing teams.
They ran statistical analyses to uncover the
risk of having two diseases together, identifying pairs of diseases for which the percentage of people who had both was higher than would be expected if the diseases were uncorrelated — in other words, a
patient who had one disease was more likely than the
average person to have the other.
[6] In the MSLT - 1 trial,
patients with isolated nodal recurrence had more total lymph nodes involved by melanoma than
patients randomized to SLN biopsy who had a positive biopsy (all of whom were to have CLND; an
average of 3.2 lymph nodes involved with metastatic melanoma vs only 1.4 positive nodes, respectively; P <.0001), [2] and were more likely to meet established criteria for adjuvant radiation, [7] which further increases the
risk of postoperative lymphedema.
We applied the
average risk of death for continued smoking estimated from studies included in this review that reported survival curves to estimate the number of
patients surviving after five years.16 17 We estimated five year survival in quitters at diagnosis by applying the death rate of continuing smokers multiplied by the reciprocal of the multivariate hazard ratio for all cause mortality presented in this review.
If a
patient tests positive for an abnormal BRCA1 or BRCA2 gene and have never had breast cancer, there is a much higher - than -
average risk of developing the deadly disease.
In a 2004 study,
patients with above -
average IGF levels had nearly a 50 % higher
risk of prostate cancer and a 65 % higher
risk of hormone - dependent premenopausal breast cancer than people with below -
average levels.
And I work with
patients daily, many of whom are sick, putting me at higher
risk than your
average person.
In a 2004 study,
patients with above -
average IGF - 1 levels had a nearly 50 % higher
risk of prostate cancer and 65 % higher
risk of hormone - dependent premenopausal breast cancer than people with below -
average levels.
Among these studies are studies on more than 19,000 children representing of 47,000
patient years of growth hormone treatment; a prospective study of 100 adult growth hormone — deficient
patients followed for 1 to 4 years, a study of 910 children treated with growth hormone for 11 years, a study of 32 adults and children followed for up to 40 years treated with growth hormone (
average 10.8 years); a study of 180 growth hormone — treated children followed for over 6 years with reduced cancer recurrence
risk (RR 0.6); a prospective analysis of 289 growth hormone — deficient adults who, after 5 years of growth hormone therapy, showed lower
risk of malignancy (RR 0.25) and decreased
risk of myocardial infarction (RR 0.19) and early mortality (RR 0.22) compared with the untreated group.
At the Masley Optimal Health Center, Dr. Masley has improved his
patients» cognitive function by an
average of 25 % while reducing their arterial plaque load and
risk of diabetes, and his book shows you how you can do the same.
We will probably go to three year intervals in our practice, as a reasonable compromise between yearly vaccinations, which do not seem necessary, and taking the
risk of loss of protection as a
patient approaches the
average time that protection is known to decrease.